Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Fluoxetine | 4 | 2005 | 732 | 0.490 |
Why?
|
| Electroconvulsive Therapy | 6 | 2006 | 505 | 0.380 |
Why?
|
| Serotonin Plasma Membrane Transport Proteins | 1 | 2013 | 326 | 0.370 |
Why?
|
| Paroxetine | 3 | 2003 | 181 | 0.370 |
Why?
|
| Citalopram | 1 | 2013 | 402 | 0.350 |
Why?
|
| Affect | 1 | 2013 | 1494 | 0.250 |
Why?
|
| Brain Chemistry | 3 | 2005 | 951 | 0.220 |
Why?
|
| Depressive Disorder | 5 | 2005 | 3712 | 0.190 |
Why?
|
| Fluorine | 1 | 2000 | 78 | 0.180 |
Why?
|
| Brain | 6 | 2013 | 27175 | 0.170 |
Why?
|
| Blood Volume | 1 | 2001 | 544 | 0.170 |
Why?
|
| Prefrontal Cortex | 2 | 2003 | 2224 | 0.120 |
Why?
|
| Cerebrovascular Circulation | 2 | 2003 | 2674 | 0.120 |
Why?
|
| Double-Blind Method | 5 | 2013 | 12426 | 0.100 |
Why?
|
| Body Fluids | 2 | 2008 | 321 | 0.080 |
Why?
|
| Pharmacogenetics | 1 | 2013 | 682 | 0.080 |
Why?
|
| Glucose | 1 | 2001 | 4335 | 0.080 |
Why?
|
| Fludrocortisone | 1 | 2008 | 24 | 0.080 |
Why?
|
| Depressive Disorder, Major | 2 | 2003 | 4809 | 0.080 |
Why?
|
| Cyproheptadine | 1 | 1987 | 21 | 0.070 |
Why?
|
| Intracranial Embolism and Thrombosis | 1 | 1987 | 143 | 0.070 |
Why?
|
| Nifedipine | 1 | 2008 | 220 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2013 | 36547 | 0.070 |
Why?
|
| Face | 1 | 2013 | 1029 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2013 | 2108 | 0.070 |
Why?
|
| Photic Stimulation | 1 | 2013 | 1989 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 4 | 2005 | 3679 | 0.070 |
Why?
|
| Mass Spectrometry | 1 | 2013 | 2197 | 0.060 |
Why?
|
| Epilepsia Partialis Continua | 1 | 2005 | 25 | 0.060 |
Why?
|
| Vaginal Smears | 1 | 2008 | 505 | 0.060 |
Why?
|
| Sodium | 2 | 2008 | 1591 | 0.060 |
Why?
|
| Stereoisomerism | 1 | 2005 | 612 | 0.060 |
Why?
|
| Photometry | 1 | 2004 | 55 | 0.060 |
Why?
|
| Tomography, Optical | 1 | 2004 | 129 | 0.050 |
Why?
|
| Leg | 1 | 2008 | 1088 | 0.050 |
Why?
|
| Cytochrome P-450 Enzyme System | 1 | 2005 | 423 | 0.050 |
Why?
|
| Infrared Rays | 1 | 2004 | 246 | 0.050 |
Why?
|
| Muscle, Skeletal | 2 | 2008 | 4960 | 0.050 |
Why?
|
| Oxygen | 1 | 2013 | 4247 | 0.050 |
Why?
|
| Choline | 1 | 2003 | 511 | 0.050 |
Why?
|
| Muscles | 1 | 2006 | 1576 | 0.050 |
Why?
|
| Caudate Nucleus | 1 | 2003 | 388 | 0.050 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2270 | 0.050 |
Why?
|
| Protons | 1 | 2006 | 1073 | 0.050 |
Why?
|
| Receptors, Dopamine | 1 | 2001 | 291 | 0.040 |
Why?
|
| Adult | 14 | 2013 | 223110 | 0.040 |
Why?
|
| Lithium | 1 | 2002 | 599 | 0.040 |
Why?
|
| Electric Stimulation Therapy | 1 | 2005 | 635 | 0.040 |
Why?
|
| Genotype | 1 | 2013 | 13027 | 0.040 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2003 | 627 | 0.040 |
Why?
|
| Tomography, Emission-Computed | 1 | 2001 | 1006 | 0.040 |
Why?
|
| Idazoxan | 1 | 1997 | 12 | 0.040 |
Why?
|
| Adrenergic alpha-2 Receptor Antagonists | 1 | 1997 | 18 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2005 | 10737 | 0.040 |
Why?
|
| Gyrus Cinguli | 1 | 2003 | 1118 | 0.030 |
Why?
|
| Bipolar Disorder | 2 | 2006 | 5128 | 0.030 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2013 | 8925 | 0.030 |
Why?
|
| Placebos | 1 | 2000 | 1659 | 0.030 |
Why?
|
| Models, Neurological | 1 | 2004 | 1746 | 0.030 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2008 | 2039 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2005 | 1498 | 0.030 |
Why?
|
| Mental Disorders | 2 | 2005 | 6870 | 0.030 |
Why?
|
| Male | 12 | 2013 | 363880 | 0.030 |
Why?
|
| Reference Values | 1 | 2001 | 4909 | 0.030 |
Why?
|
| Brain Ischemia | 1 | 2006 | 3002 | 0.030 |
Why?
|
| Humans | 18 | 2013 | 766019 | 0.020 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2001 | 2028 | 0.020 |
Why?
|
| Arousal | 1 | 1997 | 1174 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2001 | 2701 | 0.020 |
Why?
|
| Female | 12 | 2008 | 396174 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2008 | 20135 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2001 | 8723 | 0.020 |
Why?
|
| Middle Aged | 5 | 2013 | 223035 | 0.020 |
Why?
|
| Arterioles | 1 | 1987 | 251 | 0.020 |
Why?
|
| False Negative Reactions | 1 | 2008 | 570 | 0.020 |
Why?
|
| Rats, Inbred Strains | 1 | 1987 | 2077 | 0.020 |
Why?
|
| Microspheres | 1 | 1987 | 773 | 0.010 |
Why?
|
| Leukemia, Hairy Cell | 1 | 1984 | 82 | 0.010 |
Why?
|
| Absorption | 1 | 2004 | 242 | 0.010 |
Why?
|
| Uterine Cervical Dysplasia | 1 | 2008 | 391 | 0.010 |
Why?
|
| Forehead | 1 | 2004 | 75 | 0.010 |
Why?
|
| Time Factors | 1 | 2005 | 40100 | 0.010 |
Why?
|
| Herpesviridae Infections | 1 | 1984 | 268 | 0.010 |
Why?
|
| Specimen Handling | 1 | 2008 | 704 | 0.010 |
Why?
|
| Oxyhemoglobins | 1 | 2003 | 213 | 0.010 |
Why?
|
| Phosphocreatine | 1 | 2003 | 259 | 0.010 |
Why?
|
| Diffusion | 1 | 2004 | 808 | 0.010 |
Why?
|
| Rabbits | 1 | 1987 | 4730 | 0.010 |
Why?
|
| Precancerous Conditions | 1 | 2008 | 975 | 0.010 |
Why?
|
| Vasoconstriction | 1 | 2003 | 593 | 0.010 |
Why?
|
| Cerebral Angiography | 1 | 2006 | 1263 | 0.010 |
Why?
|
| Safety | 1 | 2005 | 1157 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 1984 | 1077 | 0.010 |
Why?
|
| Brain Mapping | 2 | 2004 | 6595 | 0.010 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2003 | 749 | 0.010 |
Why?
|
| Oxygen Consumption | 1 | 2003 | 1870 | 0.010 |
Why?
|
| Syndrome | 1 | 2003 | 3270 | 0.010 |
Why?
|
| Adolescent | 4 | 2008 | 88808 | 0.010 |
Why?
|
| Functional Laterality | 1 | 2003 | 2244 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2003 | 2927 | 0.010 |
Why?
|
| Prospective Studies | 1 | 2001 | 54804 | 0.010 |
Why?
|
| Monitoring, Physiologic | 1 | 2003 | 1794 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1997 | 898 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2002 | 4853 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2003 | 6020 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 1997 | 2227 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 1997 | 639 | 0.010 |
Why?
|
| Cerebral Cortex | 1 | 1987 | 5756 | 0.010 |
Why?
|
| Rats | 1 | 1987 | 23718 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2003 | 3360 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2004 | 6254 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 1987 | 18321 | 0.000 |
Why?
|
| Electroencephalography | 1 | 2003 | 6278 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 15403 | 0.000 |
Why?
|
| Age Factors | 1 | 2002 | 18382 | 0.000 |
Why?
|
| Child | 2 | 2005 | 80567 | 0.000 |
Why?
|
| Genes, Viral | 1 | 1984 | 654 | 0.000 |
Why?
|
| Sex Factors | 1 | 1997 | 10611 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 2008 | 59497 | 0.000 |
Why?
|
| Blood Pressure | 1 | 1997 | 8529 | 0.000 |
Why?
|
| Antibody Formation | 1 | 1984 | 1392 | 0.000 |
Why?
|
| Animals | 2 | 1987 | 168801 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2003 | 65203 | 0.000 |
Why?
|
| Aged | 1 | 2008 | 171170 | 0.000 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 1984 | 2838 | 0.000 |
Why?
|
| Antibodies, Viral | 1 | 1984 | 3212 | 0.000 |
Why?
|
| Mice | 1 | 1984 | 81838 | 0.000 |
Why?
|
Concepts
(127)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(9)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_